Models of rhinovirus-C respiratory infection and asthma
Models of rhinovirus-C respiratory infection and asthma
批准号:
10268220
负责人:
Marc B. Hershenson
金额:
$42.21万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-22 至 2025-08-31
关键词:
4 year oldAdrenal Cortex HormonesAirAirway DiseaseAllelesAllergicAnimal ModelAspirate substanceAsthmaBronchiolitisCadherinsCell surfaceCellsChildCytoplasmDataDevelopmentDexamethasoneDiagnosisDiseaseEpithelialEpithelial CellsFamilyFamily memberFlow CytometryGene ExpressionGenotypeHela CellsHospitalizationHumanIL2RA geneIL7R geneIn VitroIndividualInfantInfectionIntercellular adhesion molecule 1Interleukin-13LeadLifeLinkLiquid substanceLow-Density LipoproteinsLungLymphoid CellMeasuresMetaplasiaModelingMucinsMucous body substanceMusNosePathogenesisPhenotypePhosphotransferasesPhysiciansPilot ProjectsProductionProspective StudiesPyroglyphidaeRefractoryResearch PersonnelResistanceRespiratory Tract InfectionsRhinovirusRhinovirus infectionRoleSamplingSignal PathwaySteroidsTSLP geneTestingTherapeutic InterventionUniversitiesVariantViralVirusVirus DiseasesWisconsinairway epitheliumairway hyperresponsivenessairway inflammationasthma exacerbationasthmaticcellular transductioncytokineeosinophileosinophilic inflammationexperimental studyhigh riskhuman subjectin vivoinsightmacrophageneutralizing antibodyoverexpressionreceptorresponsevirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Accumulating evidence indicates that infections with a newly-discovered species of rhinovirus, RV-C, are asso-
ciated with severe respiratory tract infections and asthma exacerbations often requiring hospitalization. In addi-
tion, recent data suggest a possible role for early-life RV-C infections in asthma development.
Despite increasing recognition of RV-C as a cause of asthmatic disease, virtually nothing is known about
the pathogenesis of RV-C infections. To accomplish this, we infected mice with RV-C15 (the RV-C15 infec-
tious clone and HeLa-E8 cells overexpressing a variant of the human RV-C receptor, cadherin related family
member 3, were obtained from James Gern, University of Wisconsin). Our pilot studies show that RV-C15-
infected mice show increased type 2 cytokine and mucin gene expression, BAL eosinophils and lineage-nega-
tive, CD25+, CD127+ type 2 innate lymphoid cells (ILC2s) compared to RV-A1B-infected mice. In addition, pi-
lot studies from children with natural RV-C infections show increased type 2 cytokine production.
In this application, we will test the general hypothesis that, after RV-C infection, airway innate cytokine ex-
pression drives ILC2 expansion and development of eosinophilic inflammation and mucous metaplasia. To test
this hypothesis, we propose the following Specific Aims:
Specific Aim 1. Determine the contribution of epithelial-derived innate cytokines to RV-C15-induced
eosinophilic airway inflammation and hyperresponsiveness (AHR). We hypothesize that: 1) compared to
RV-A, RV-C infection of mature mice induces greater lung expression of innate cytokines (IL-25, IL-33, TSLP);
2) IL-25 is produced by doublecortin-like kinase (DCLK)-1-positive airway tuft cells; 3) innate cytokines are re-
quired for eosinophilic inflammation; 4) RV-C engagement of CDHR3 activates distinct signaling pathways
leading to innate cytokine expression.
Specific Aim 2. Determine the contribution of lung ILC2s and macrophages to RV-C-induced airway
inflammation and AHR. We hypothesize that: 1) RV-C infection of mature mice induces innate cytokine-de-
pendent expansion of ILC2s; 2) ILC2s promote eosinophilic inflammation, macrophage polarization and AHR;
3) house dust mite (HDM) and RV-C have additive effects on eosinophilic inflammation and AHR; 4) ILC2s
convey corticosteroid resistance; and 5) nasal aspirates from human subjects infected with RV-C show in-
creased expression of type 2 cytokines and ILC2s compared to samples from RV-A-infected subjects.
Specific Aim 3. Determine the effects of early-life RV-C infection on the established asthma pheno-
type. We have found that RV-A1B infection of six day-old mice, but not mature mice, induces long-lasting mu-
cous metaplasia and AHR which is dependent on IL-13-producing ILC2s. We hypothesize that: 1) RV-C infec-
tion of 6 day-old mice induces greater and more long-lasting mucous metaplasia than RV-A; 2) early-life RV-C
infection increases the number of IL-25-producing airway tuft cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10093541
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10682418
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10459511
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Respiratory Enteroviruses, Inflammasome Activation and Innate Immune Cells
-
批准号:10299951
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:9128143
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2016
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:9233004
-
项目类别:
-
资助金额:$44.67万
-
财政年份:2016
-
负责人:Marc B. Hershenson
-
依托单位:
S-Nitrosothiol-Based Rinse/Aerosol Solutions For Treatment/Prevention of Rhinosinusitis
-
批准号:8980847
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10443694
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10200651
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10651800
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:7822366
-
项目类别:
-
资助金额:$2.4万
-
财政年份:2009
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7642308
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7497962
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7334302
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7666430
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7877980
-
项目类别:
-
资助金额:$40.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7881828
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:7386619
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位:
Mechanisms of Airway Smooth Muscle Hypertrophy
-
批准号:7266235
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:8039582
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位: